Financhill
Back

Hepion Pharmaceuticals Stock Predictions

Hepion Pharmaceuticals Stock Forecast

  • Is Hepion Pharmaceuticals Stock Undervalued?
    The current Hepion Pharmaceuticals [HEPA] share price is $2.45. The Score for HEPA is 48, which is 4% below its historic median score of 50, and infers higher risk than normal.
  • HEPA is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.

Will Hepion Pharmaceuticals Stock Go Up Next Year?

Data Unavailable

Hepion Pharmaceuticals Stock Rating

Data Unavailable

Hepion Pharmaceuticals Stock Price History

Is HEPA stock going to rise?

  • Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and HEPA is experiencing slight selling pressure.

Stock Information

Stock Info

Exchange:
NASDAQ
Country:
United States
Industry:
Biotechnology
Sector:
Healthcare
Type:
stock
Website:
hepionpharma.com

52-Week Data

52-Week High:
20.66
52-Week Low:
1.49

Prediction Charts

Market Cap:
10.63M
Price in USD:
2.45
Volume:
20.87K
Beta:
1.54

Technical Analysis

SMA50:
2.18
SMA100:
2.70
SMA200:
4.98
52-Wk Change:
-81.99%

Stock Predictions

  • Is Hepion Pharmaceuticals stock public?
    Yes, Hepion Pharmaceuticals is a publicly traded company.
  • What is the Hepion Pharmaceuticals stock quote today?
    The Hepion Pharmaceuticals stock price is 2.45 USD today.
  • How to buy Hepion Pharmaceuticals stock online?
    You can buy Hepion Pharmaceuticals shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.

14-Day Historical Data

Date Opening Closing Minimum Maximum
Mar-11 2.30 2.24 2.38 2.15
Mar-12 2.23 2.18 2.24 2.08
Mar-13 2.12 2.09 2.44 2.02
Mar-14 2.07 2.04 2.31 1.89
Mar-15 2.20 2.32 2.36 1.96
Mar-18 2.07 2.20 2.21 2.07
Mar-19 2.20 2.13 2.29 2.07
Mar-20 2.11 2.34 2.35 2.05
Mar-21 2.21 2.32 2.34 2.20
Mar-22 2.32 2.34 2.42 2.05
Mar-25 2.28 2.25 2.37 2.21
Mar-26 2.25 2.32 2.41 2.25
Mar-27 2.30 2.34 2.56 2.22
Mar-28 2.47 2.45 2.53 2.42

Hepion Pharmaceuticals Earnings

Data Unavailable

Hepion Pharmaceuticals Forecast Revenue Growth

Data Unavailable

  • Analysts estimate an earnings increase this quarter of $1.22 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.27 per share, and a decrease next year of $0.00 per share.

* Hepion Pharmaceuticals stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.